Watchlist Price Alert

Nabriva Therapeutics (NBRV)

NASDAQ: NBRV · Real-Time Price · USD

1.42

0.01 (0.71%)

At close: Jul 31, 2023, 8:00 PM

Nabriva Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-57.19M	-49.45M	-69.48M	-82.76M	-114.78M	-74.36M	-54.89M
Depreciation & Amortization	217K	637K	820K	770K	510K	432K	233K
Stock-Based Compensation	1.97M	3.29M	5.22M	9.75M	5.15M	5.73M	2.54M
Other Working Capital	-1.21M	365K	1.45M	-3.4M	7M	-3.91M	5.92M
Other Non-Cash Items	4.56M	822K	748K	549K	32.37M	-1.24M	-16K
Deferred Income Tax	n/a	n/a	2.76M	n/a	n/a	1.41M	-794K
Change in Working Capital	13.73M	-14.86M	-11.39M	-195K	4.03M	-1.33M	3.6M
Operating Cash Flow	-36.71M	-59.56M	-71.33M	-71.89M	-72.72M	-69.35M	-49.32M
Capital Expenditures	-211K	-25K	-113K	-61K	-229K	-1.17M	-603K
Cash Acquisitions	n/a	n/a	n/a	n/a	-4.26M	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	-115K	-30K	-57.05M
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	4.26M	50.95M	81M
Other Investing Acitivies	-52K	-56K	-161K	392K	-4.26M	2K	44.4M
Investing Cash Flow	-263K	-81K	-274K	331K	-4.6M	49.75M	23.35M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.85M	66.37M	26.92M	56.08M	92.92M	72.22M	22.3M
Financial Cash Flow	1.85M	66.37M	26.92M	56.08M	92.92M	72.22M	22.3M
Net Cash Flow	-35.3M	6.24M	-44.82M	-15.59M	15.23M	53.99M	-3.67M
Free Cash Flow	-36.92M	-59.58M	-71.44M	-71.95M	-72.95M	-70.52M	-49.92M